http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003137790-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e96f34eb301d7384da3ed77fd73138e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
filingDate 2001-11-01^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_175aa30362690813c234c777665e0469
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f5ebab1114d6aeaa5813aeaf0bb1c2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62fb3c498ae1f43e094758b5374269f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_442efa16d49d2a2836345587f6dbca42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_262325348b3788d4d756917e14ab6810
publicationDate 2003-05-14^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003137790-A
titleOfInvention Pharmaceutical containing fructooligosaccharide containing β-2,1 (β2 → β1) linked fructose oligomer as active ingredient
abstract (57) [Summary] An object of the present invention is to provide a drug which is excellent in safety, can be widely used on a daily basis, and is capable of preventing and improving a decrease in immune function widely. Kind Code: A1 The present invention provides a preventive and / or ameliorating agent for reducing immune function, comprising a fructooligosaccharide containing β-2,1 (β2 → β1) -linked fructose oligomer as an active ingredient, an agent for promoting immune function persistence, and opportunistic infection. The present invention relates to a preventive and / or ameliorating agent for a disease, an agent for enhancing tumor immunity, and an agent for preventing and / or ameliorating a decrease in biological regulation function. Fructooligosaccharides containing a β-2,1 (β2 → β1) -linked fructose oligomer, which is an active ingredient of each of these drugs, can be obtained by allowing β-fructofuranosidase to act on sucrose derived from various foods.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785495-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10265335-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785496-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8796333-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115336758-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012176907-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009519328-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007530542-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8778994-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8778992-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8778993-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006030100-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8916217-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2874825-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9521859-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015147773-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011027128-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012229227-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9693577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609725-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9241508-B2
priorityDate 2001-11-01^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1282
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440080
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO42878
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ74K42
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCJ7HDY4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DJA4
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID1938033
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5061
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166775
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5580
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3WYV9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415860956
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y746
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24133
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523310
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6BJW6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407699550
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3085157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5984
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425966723
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID5580
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO59852
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID2405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1282
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID1938033
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588466
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF8DT27
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID5061
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3684

Showing number of triples: 1 to 82 of 82.